These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 22222916)
1. In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis. Sheehy A; Gutiérrez-Chico JL; Diletti R; Oberhauser JP; Glauser T; Harrington J; Kossuth MB; Rapoza RJ; Onuma Y; Serruys PW EuroIntervention; 2012 Feb; 7(10):1227-35. PubMed ID: 22222916 [TBL] [Abstract][Full Text] [Related]
2. Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process. Gutiérrez-Chico JL; Gijsen F; Regar E; Wentzel J; de Bruyne B; Thuesen L; Ormiston J; McClean DR; Windecker S; Chevalier B; Dudek D; Whitbourn R; Brugaletta S; Onuma Y; Serruys PW JACC Cardiovasc Interv; 2012 Apr; 5(4):428-35. PubMed ID: 22516401 [TBL] [Abstract][Full Text] [Related]
3. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial. Onuma Y; Serruys PW; Perkins LE; Okamura T; Gonzalo N; García-García HM; Regar E; Kamberi M; Powers JC; Rapoza R; van Beusekom H; van der Giessen W; Virmani R Circulation; 2010 Nov; 122(22):2288-300. PubMed ID: 20975003 [TBL] [Abstract][Full Text] [Related]
4. Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice. Farooq V; Serruys PW; Heo JH; Gogas BD; Onuma Y; Perkins LE; Diletti R; Radu MD; Räber L; Bourantas CV; Zhang Y; van Remortel E; Pawar R; Rapoza RJ; Powers JC; van Beusekom HM; Garcìa-Garcìa HM; Virmani R JACC Cardiovasc Interv; 2013 May; 6(5):523-32. PubMed ID: 23702016 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Serruys PW; Onuma Y; Ormiston JA; de Bruyne B; Regar E; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Miquel-Hebert K; Rapoza R; García-García HM Circulation; 2010 Nov; 122(22):2301-12. PubMed ID: 21098436 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. Serruys PW; Onuma Y; Dudek D; Smits PC; Koolen J; Chevalier B; de Bruyne B; Thuesen L; McClean D; van Geuns RJ; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Sudhir K; Garcia-Garcia HM; Ormiston JA J Am Coll Cardiol; 2011 Oct; 58(15):1578-88. PubMed ID: 21958884 [TBL] [Abstract][Full Text] [Related]
8. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study. Davlouros PA; Nikokiris G; Karantalis V; Mavronasiou E; Xanthopoulou I; Damelou A; Tsigkas G; Alexopoulos D Int J Cardiol; 2011 Sep; 151(2):155-9. PubMed ID: 20605242 [TBL] [Abstract][Full Text] [Related]
9. Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography. Yao ZH; Matsubara T; Inada T; Suzuki Y; Suzuki T Chin Med J (Engl); 2008 Mar; 121(6):503-7. PubMed ID: 18364133 [TBL] [Abstract][Full Text] [Related]
10. Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial. Bourantas CV; Farooq V; Zhang Y; Muramatsu T; Gogas BD; Thuesen L; McClean D; Chevalier B; Windecker S; Koolen J; Ormiston J; Whitbourn R; Dorange C; Rapoza R; Onuma Y; Garcia-Garcia HM; Serruys PW EuroIntervention; 2015 Mar; 10(11):1299-306. PubMed ID: 24769420 [TBL] [Abstract][Full Text] [Related]
11. Neointimal coverage on drug-eluting stent struts crossing side-branch vessels using optical coherence tomography. Her AY; Lee BK; Shim JM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK Am J Cardiol; 2010 Jun; 105(11):1565-9. PubMed ID: 20494663 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of neointimal coverage of overlapping sirolimus-eluting stents by optical coherence tomography. Tian F; Chen YD; Sun ZJ; Chen L; Yuan F; Song XT; Lü SZ Chin Med J (Engl); 2009 Mar; 122(6):670-4. PubMed ID: 19323932 [TBL] [Abstract][Full Text] [Related]
13. Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of pilot results for future pre-clinical studies. Gogas BD; Radu M; Onuma Y; Perkins L; Powers JC; Gomez-Lara J; Farooq V; Garcia-Garcia HM; Diletti R; Rapoza R; Virmani R; Serruys PW Int J Cardiovasc Imaging; 2012 Mar; 28(3):499-511. PubMed ID: 21503708 [TBL] [Abstract][Full Text] [Related]
14. Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography. Gomez-Lara J; Radu M; Brugaletta S; Farooq V; Diletti R; Onuma Y; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW JACC Cardiovasc Interv; 2011 Sep; 4(9):992-1001. PubMed ID: 21939939 [TBL] [Abstract][Full Text] [Related]
15. A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds. Gomez-Lara J; Brugaletta S; Diletti R; Garg S; Onuma Y; Gogas BD; van Geuns RJ; Dorange C; Veldhof S; Rapoza R; Whitbourn R; Windecker S; Garcia-Garcia HM; Regar E; Serruys PW Eur Heart J; 2011 Feb; 32(3):294-304. PubMed ID: 21123276 [TBL] [Abstract][Full Text] [Related]
16. Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque? Brugaletta S; Radu MD; Garcia-Garcia HM; Heo JH; Farooq V; Girasis C; van Geuns RJ; Thuesen L; McClean D; Chevalier B; Windecker S; Koolen J; Rapoza R; Miquel-Hebert K; Ormiston J; Serruys PW Atherosclerosis; 2012 Mar; 221(1):106-12. PubMed ID: 22209268 [TBL] [Abstract][Full Text] [Related]
17. Serial assessment of coronary artery response to paclitaxel-eluting stents using optical coherence tomography. Guagliumi G; Bezerra HG; Sirbu V; Ikejima H; Musumeci G; Biondi-Zoccai G; Lortkipanidze N; Fiocca L; Capodanno D; Wang W; Tahara S; Vassileva A; Matiashvili A; Valsecchi O; Costa MA Circ Cardiovasc Interv; 2012 Feb; 5(1):30-8. PubMed ID: 22298797 [TBL] [Abstract][Full Text] [Related]
18. Preliminary observations using optical coherence tomography to assess neointimal coverage of a metal stent in a porcine model. Mills JS; N'diaye CS; Yow E; Urtz M; Povsic TJ; Greenfield JC; Phillips HR Cardiovasc Revasc Med; 2009; 10(4):229-35. PubMed ID: 19815170 [TBL] [Abstract][Full Text] [Related]
19. Optical coherence tomography at follow-up after percutaneous coronary intervention: relationship between procedural dissections, stent strut malapposition and stent healing. Radu M; Jørgensen E; Kelbæk H; Helqvist S; Skovgaard L; Saunamäki K EuroIntervention; 2011 Jul; 7(3):353-61. PubMed ID: 21729838 [TBL] [Abstract][Full Text] [Related]